Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 9Gynecologic 4Dermatologic 4Gastrointestinal 3Thoracic 2Plasma cell 2Head & Neck 2Genitourinary 2CNS 1Breast 1

Conditions

Carcinoma, Renal Cell 17Melanoma 16Kidney Neoplasms 11Neoplasm Metastasis 10Uterine Cervical Neoplasms 9Prostatic Neoplasms 9Breast Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Anus Neoplasms 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Penile Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Lymphoma 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Vulvar Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Wilms Tumor 2

Interventions

fludarabine 2Ifosfamide 2Filgrastim 2Doxorubicin 2Cyclophosphamide 2tazemetostat 1pembrolizumab 1lorvotuzumab mertansine 1ixabepilone 1cixutumumab 1Radiotherapy 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Chemotherapy, Adjuvant 1CLR1404 1Biological Therapy 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Synovial × fludarabine × Genitourinary × Clear all
NCT02869217 2025-12-03

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

University Health Network, Toronto

Phase 1 Active not recruiting
22 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

NCT02457650 2016-08-03

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Shenzhen Second People's Hospital

Phase 1 Unknown
36 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡